Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-035453
Filing Date
2014-05-20
Accepted
2014-05-20 14:45:22
Documents
1
Period of Report
2014-05-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3894
  Complete submission text file 0001209191-14-035453.txt   5625
Mailing Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009
Business Address 2500 NORTHWINDS PARKWAY, SUITE 100 ALPHARETTA 2Q 30009 301-770-3099
Biota Pharmaceuticals, Inc. (Issuer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ADOLOR CORP 700 PENNSYLVANIA DR EXTON PA 19341
Business Address
DOUGHERTY MICHAEL R (Reporting) CIK: 0001033516 (see all company filings)

State of Incorp.: PA | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35285 | Film No.: 14857538